Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Disorders"

429 News Found

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi
News | May 18, 2026

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi

New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches


Women’s hospital opens in Delhi with $5 million backing
Hospitals | May 18, 2026

Women’s hospital opens in Delhi with $5 million backing

30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage


Experts calls for urgent preventive action as hypertension cases rise
Healthcare | May 18, 2026

Experts calls for urgent preventive action as hypertension cases rise

Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare


RAG launches lupus patient support group in Ahmedabad
Healthcare | May 18, 2026

RAG launches lupus patient support group in Ahmedabad

The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care


Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Biopharma | May 18, 2026

Kotak Alts invests Rs. 200 million in Cellogen Therapeutics

Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities


Vyome secures exclusive license from Impetis for selective JAK inhibitor programs
News | May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments


AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management
Healthcare | May 13, 2026

AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management

Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure


NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs
R&D | May 12, 2026

NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs

In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike


Sebia India and CAHO launch autoimmunity masterclass series
Healthcare | May 11, 2026

Sebia India and CAHO launch autoimmunity masterclass series

The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases